The market for advanced cell models is booming and expected to grow from $1.42 billion in 2022 to $5.29 billion by 2032. This surge is driven by the unique properties of advanced cell models: They can ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...